We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Click here to add this to my saved trials
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Dysport® Adult Lower Limb Spasticity Follow-on Study
Updated: 11/8/2017
A Phase III, Prospective, Multicentre, Open Label, Extension Study, to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injection in the Treatment of Lower Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 11/8/2017
Click here to add this to my saved trials
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures
Updated: 11/9/2017
An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Phenobarbital as Adjunctive Therapy in Participants (> or = 17 to 70 Years Old) With Partial Onset Seizures
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Updated: 11/9/2017
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated: 11/9/2017
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Updated: 11/9/2017
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Updated: 11/9/2017
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated: 11/9/2017
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Updated: 11/9/2017
A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
Updated: 11/9/2017
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
Status: Enrolling
Updated: 11/9/2017
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
Updated: 11/9/2017
Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Updated: 11/9/2017
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Status: Enrolling
Updated: 11/9/2017
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Updated: 11/9/2017
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Updated: 11/9/2017
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Status: Enrolling
Updated: 11/9/2017
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Updated: 11/9/2017
Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Updated: 11/9/2017
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Status: Enrolling
Updated: 11/9/2017
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Updated: 11/9/2017
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke
Updated: 11/9/2017
Donepezil/ Galantamine in the Treatment of Post-stroke Cognitively Impaired Rehabilitating Elderly
Status: Enrolling
Updated: 11/9/2017
Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke
Updated: 11/9/2017
Donepezil/ Galantamine in the Treatment of Post-stroke Cognitively Impaired Rehabilitating Elderly
Status: Enrolling
Updated: 11/9/2017
Click here to add this to my saved trials
Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults
Updated: 11/13/2017
Improving Outcomes in Geriatric Depression: Magnetic Seizure Therapy
Status: Enrolling
Updated: 11/13/2017
Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults
Updated: 11/13/2017
Improving Outcomes in Geriatric Depression: Magnetic Seizure Therapy
Status: Enrolling
Updated: 11/13/2017
Click here to add this to my saved trials
Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia
Updated: 11/13/2017
A Randomized, Double-blind, Placebo-controlled, Multiple Oral Dose Escalation for Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia.
Status: Enrolling
Updated: 11/13/2017
Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia
Updated: 11/13/2017
A Randomized, Double-blind, Placebo-controlled, Multiple Oral Dose Escalation for Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia.
Status: Enrolling
Updated: 11/13/2017
Click here to add this to my saved trials
Cognitive ADHD Videogame Exploratory Study
Updated: 11/14/2017
A Study to Assess the Feasibility of EVO Gameplay to Engage Children With Attention Deficit Hyperactivity Disorder (ADHD) and to Evaluate Cognitive Interference in Children Ages 8 to 12 Years Old With ADHD Compared to Neuro-typical Children
Status: Enrolling
Updated: 11/14/2017
Cognitive ADHD Videogame Exploratory Study
Updated: 11/14/2017
A Study to Assess the Feasibility of EVO Gameplay to Engage Children With Attention Deficit Hyperactivity Disorder (ADHD) and to Evaluate Cognitive Interference in Children Ages 8 to 12 Years Old With ADHD Compared to Neuro-typical Children
Status: Enrolling
Updated: 11/14/2017
Click here to add this to my saved trials
Cognitive ADHD Videogame Exploratory Study
Updated: 11/14/2017
A Study to Assess the Feasibility of EVO Gameplay to Engage Children With Attention Deficit Hyperactivity Disorder (ADHD) and to Evaluate Cognitive Interference in Children Ages 8 to 12 Years Old With ADHD Compared to Neuro-typical Children
Status: Enrolling
Updated: 11/14/2017
Cognitive ADHD Videogame Exploratory Study
Updated: 11/14/2017
A Study to Assess the Feasibility of EVO Gameplay to Engage Children With Attention Deficit Hyperactivity Disorder (ADHD) and to Evaluate Cognitive Interference in Children Ages 8 to 12 Years Old With ADHD Compared to Neuro-typical Children
Status: Enrolling
Updated: 11/14/2017
Click here to add this to my saved trials
A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis
Updated: 11/14/2017
A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis
Status: Enrolling
Updated: 11/14/2017
A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis
Updated: 11/14/2017
A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis
Status: Enrolling
Updated: 11/14/2017
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Updated: 11/15/2017
A 3-year, Multi-center Study to Evaluate Optical Coherence Tomography as an Outcome Measure in Patients With Multiple Sclerosis
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Telehealth Coaching for Families of Children With Autism
Updated: 11/15/2017
Telehealth Coaching for Families of Children With Autism
Status: Enrolling
Updated: 11/15/2017
Telehealth Coaching for Families of Children With Autism
Updated: 11/15/2017
Telehealth Coaching for Families of Children With Autism
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Oral Immunotherapy for Childhood Egg Allergy
Updated: 11/15/2017
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Oral Immunotherapy for Childhood Egg Allergy
Updated: 11/15/2017
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Oral Immunotherapy for Childhood Egg Allergy
Updated: 11/15/2017
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Oral Immunotherapy for Childhood Egg Allergy
Updated: 11/15/2017
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Oral Immunotherapy for Childhood Egg Allergy
Updated: 11/15/2017
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Oral Immunotherapy for Childhood Egg Allergy
Updated: 11/15/2017
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Oral Immunotherapy for Childhood Egg Allergy
Updated: 11/15/2017
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Oral Immunotherapy for Childhood Egg Allergy
Updated: 11/15/2017
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
Oral Immunotherapy for Childhood Egg Allergy
Updated: 11/15/2017
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Oral Immunotherapy for Childhood Egg Allergy
Updated: 11/15/2017
Oral Desensitization to Egg With Subsequent Induction of Tolerance for Egg-Allergic Children (CoFAR 3)
Status: Enrolling
Updated: 11/15/2017
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases
Updated: 11/17/2017
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of ABT-888 in Combination With Whole Brain Radiation Therapy in Subjects With Brain Metastases
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
Trauma Survivors Outcomes and Support Study IV
Updated: 11/17/2017
Integrating Information Technology Advancements Into Early PTSD Interventions
Status: Enrolling
Updated: 11/17/2017
Trauma Survivors Outcomes and Support Study IV
Updated: 11/17/2017
Integrating Information Technology Advancements Into Early PTSD Interventions
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage
Updated: 11/17/2017
Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH)
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials